Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.88%
1,100.61
-9.73
-0.88%
—1,110.341,110.371,117.241,097.84——
SIXC
Communications
SIXC
Communications
SIXC
-1.33%
612.30
-8.24
-1.33%
—620.54620.54622.67611.42——
SIXE
Energy
SIXE
Energy
SIXE
+1.40%
1,175.46
+16.26
+1.40%
—1,159.201,160.591,177.621,156.21——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.39%
1,729.12
-24.32
-1.39%
—1,753.441,749.081,762.011,724.74——
SIXM
Financials
SIXM
Financials
SIXM
-0.63%
644.73
-4.07
-0.63%
—648.80649.58655.73643.68——
SIXR
Staples
SIXR
Staples
SIXR
-0.65%
827.09
-5.40
-0.65%
—832.49832.07833.09826.15——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.98%
214.82
-4.34
-1.98%
—219.16219.16219.19214.82——
SIXT
Technology
SIXT
Technology
SIXT
+0.06%
3,115.17
+1.81
+0.06%
—3,113.363,120.793,143.643,105.16——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.75%
910.43
-16.24
-1.75%
—926.67927.99930.54910.08——
SIXV
Health care
SIXV
Health care
SIXV
-1.01%
1,474.50
-15.11
-1.01%
—1,489.611,499.051,499.051,474.35——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,405.87
-17.39
-0.72%
—2,423.262,438.162,443.462,399.83——
2LB:FRA
Iovance Biotherapeutics Inc
€3.17
-0.16%
(-0.0050) 1D
Apr 22, 8:00:08 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 2LB...
Open
€3.17
High
€3.17
Low
€3.17
Mkt. cap
1.52B
Avg. vol.
1.14K
Volume
0.00
52-wk high
€4.74
52-wk low
€1.43
No. of employees
975
News stories
From sources across the web
Profile
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
About Iovance Biotherapeutics Inc
CEO-
Employees975
Founded2007
HeadquartersSan Carlos, California, United States
SectorBiotechnology
Websiteiovance.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
49.32M
59.95M
67.46M
86.77M
Cost of goods sold
49.74M
56.66M
38.48M
43.11M
Cost of revenue
49.74M
56.66M
38.48M
43.11M
Research and development expenses
76.88M
79.36M
75.17M
71.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.92M
37.70M
34.56M
36.40M
Operating expense
120.80M
117.06M
118.74M
117.12M
Total operating expenses
170.54M
173.73M
157.21M
160.23M
Operating income
-121.22M
-113.77M
-89.76M
-73.46M
Other non operating income
-
-
-
-2.71M
EBT including unusual items
-118.00M
-109.67M
-93.66M
-71.72M
EBT excluding unusual items
-120.15M
-109.67M
-88.52M
-73.06M
Income tax expense
-1.84M
1.99M
-2.40M
184.00K
Effective tax rate
1.56%
-1.81%
2.57%
-0.26%
Other operating expenses
-
-
-
-
Net income
-116.16M
-111.66M
-91.25M
-71.90M
Net profit margin
-235.51%
-186.25%
-135.28%
-82.87%
Earnings per share
-0.36
-0.33
-0.25
-0.18
Interest and investment income
1.07M
4.10M
1.24M
3.10M
Interest expense
-
-
-
-
Net interest expenses
1.07M
4.10M
1.24M
3.10M
Depreciation and amortization charges
-
-
9.01M
9.52M
EBITDA
-113.03M
-104.71M
-81.00M
-63.53M
Gain or loss from assets sale
44.00K
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer